You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 21, 2024

TRAVASOL 8.5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Travasol 8.5% In Plastic Container patents expire, and when can generic versions of Travasol 8.5% In Plastic Container launch?

Travasol 8.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in TRAVASOL 8.5% IN PLASTIC CONTAINER is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.

Summary for TRAVASOL 8.5% IN PLASTIC CONTAINER
Drug patent expirations by year for TRAVASOL 8.5% IN PLASTIC CONTAINER
Recent Clinical Trials for TRAVASOL 8.5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McGill University Health CenterPhase 4
Canadian Institutes of Health Research (CIHR)Phase 4
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 4

See all TRAVASOL 8.5% IN PLASTIC CONTAINER clinical trials

Pharmacology for TRAVASOL 8.5% IN PLASTIC CONTAINER
Drug ClassAmino Acid
Anatomical Therapeutic Chemical (ATC) Classes for TRAVASOL 8.5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for TRAVASOL 8.5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare TRAVASOL 8.5% IN PLASTIC CONTAINER amino acids INJECTABLE;INJECTION 018931-002 Aug 23, 1984 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride INJECTABLE;INJECTION 020173-002 Oct 27, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.